Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.190
-0.040 (-3.25%)
At close: Apr 28, 2026, 4:00 PM EDT
1.200
+0.010 (0.84%)
After-hours: Apr 28, 2026, 7:06 PM EDT
Bionano Genomics Stock Forecast
BNGO's stock price has decreased by -72.33% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bionano Genomics stock have an average target of 7.00, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 488.24% from the current stock price of 1.19.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bionano Genomics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +404.20% | Apr 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $7 | Strong Buy | Maintains | $11 → $7 | +488.24% | Nov 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +824.37% | Aug 18, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +572.27% | May 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +740.34% | Apr 9, 2025 |
Financial Forecast
Revenue This Year
32.78M
from 28.51M
Increased by 14.99%
Revenue Next Year
44.17M
from 32.78M
Increased by 34.73%
EPS This Year
-2.54
from -4.85
EPS Next Year
-1.24
from -2.54
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 34.1M | 45.5M | ||||||
| Avg | 32.8M | 44.2M | ||||||
| Low | 31.2M | 42.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 19.6% | 38.7% | ||||||
| Avg | 15.0% | 34.7% | ||||||
| Low | 9.3% | 29.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.61 | -1.28 | ||||||
| Avg | -2.54 | -1.24 | ||||||
| Low | -2.44 | -1.20 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.